La Vague
A review of Rouging
October 2021 La Vague n°71 Congrès A3P : Annex 1, Single Use, Remote Audit Download PDF Summary ✻ A review of Rouging. Impact des technologies à usage unique sur [...]
Leggi di piùNon categorizzato
Conference confirmation – Validation of disinfectant 2021
Conference confirmation A3P Italy - Validation of disinfectant October 21st 2021 ✻
Leggi di piùNon categorizzato
Call for paper – A3P Convalida dei disinfettanti – 21 Octobre 2021
Call for paper A3P Convalida dei disinfettanti 21 ottobre 2021 - Milano ✻
Leggi di piùNon categorizzato
Speaker Confirmation Form A3P Barrier Technology 2021
Speaker confirmation form A3P Barrier Technology - 14 & 15 september 2021 ✻
Leggi di piùEventi
Webinar A3P Medical Devices – 26 & 27 mai 2021
MEDICAL DEVICES Regulatory / Classification of DM / Pre-clinical & clinical evaluation procedure Location Online Date May 26th and 27th, 2021 Save The Date ! Format Visioconferences Share Linkedin Send [...]
Leggi di piùNon categorizzato
Speaker Confirmation Form A3P Process Control October 2021
Speaker Confirmation Form A3P Process Control - October 6th & 7th 2021 ✻
Leggi di più
Non categorizzato
France’s Sanofi to buy US group Principia Biopharma for $3.68 bln
Paris, Aug 17, 2020 (AFP) – French pharma giant Sanofi said Monday it will buy US group Principia Biopharma for $3.68 billion in a deal that will boost its research and development into autoimmune and allergic diseases
Non categorizzato
Amazon launches online pharmacy in India
Mumbai, Aug 14, 2020 (AFP) – US tech giant Amazon launched its first Indian online pharmacy service on Friday as it attempts to grab more of the country’s burgeoning e-commerce market
Non categorizzato
WHO urges countries to gamble on shared vaccine search
Geneva, Aug 13, 2020 (AFP) – The WHO on Thursday urged countries to invest billions of dollars in searching for COVID-19 vaccines and treatments — calling it a snip compared to the vast economic cost of the coronavirus crisis
Non categorizzato
US promises $2.1 bn for Sanofi, GSK coronavirus vaccine
Paris, July 31, 2020 (AFP) – Pharma giants Sanofi and GSK are to receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus epidemic.
